Teva Pharm USA Inc. | Buyer Report — Panjiva
MENU

Supply Chain Intelligence about:

Teva Pharm USA Inc.

Company profile   United States

See Teva Pharm USA Inc.'s products and suppliers

Thousands of companies like you use Panjiva to research suppliers and competitors.

Easy access to trade data

Cleaned and organized India shipments

3 India shipments available for Teva Pharm USA Inc.
Date Data Source Supplier Details
2017-07-29 India Export Shipments
CIPLA LIMITED.
ESCITALOPRAM TABS USP 10MG; NDC No. 0009 3-5851-05 (1X500'S/PAC) (BATCH NO.KA7247 7)
2017-12-12 India Export Shipments
CIPLA LIMITED.
ESCITALOPRAM TABS USP 20MG; NDC NO.00093-5852-05(PACK SIZE:1X500'S), (TAX INV NO:1301392692 DT:11.12.2017. LUT NO. 03/17-18 DT: 06.07.2017VALID UPTO 31.03.2018)
2018-10-29 India Export Shipments
CIPLA LIMITED.
ESCITALOPRAM TABS USP 10MG; NDC No. 0009 3-5851-05 (1X500'S/PAC) (BATCH NO.KA7247 7)
Shipment data shows what products a company is trading and more. Learn more

Explore trading relationships hidden in supply chain data


Sample Bill of Lading

3 shipment records available

Bill of Lading Number
7690954
HS Code
30049089
Goods Described
ESCITALOPRAM TABS USP 10MG; NDC No. 0009 3-5851-05 (1X500'S/PAC) (BATCH NO.KA7247 7)
Item Quantity
9672.0
Item Quantity Unit
PAC
Item Value, FOB (INR)
3654320.0
Departure Date
2017-07-29
Shipper
Cipla Ltd.
Shipper (Original Format)
CIPLA LIMITED.
Shipper Global HQ
Cipla Ltd.
Shipper Domestic HQ
Cipla Ltd.
Consignee
Teva Pharm USA Inc.
Consignee (Original Format)
TEVA PHARM USA, INC,
Port of Unlading
New York (US)
Port of Lading
Mumbai (ex Bombay) (IN)
Shipment Destination
United States
Transport Method
Air
Item Number
1
Value of Goods (USD)
56978.5608482108053238752
Value of Goods, FOB (INR)
3654320.0

Recent Panjiva Research about Teva Pharm USA Inc.

20171215-teva-total

Could Croatia Pay The Price For Netanyahu’s Teva Request?

Teva Pharma has launched a significant restructuring program, designed to cut 19% from its cost base after significant price deflation and sector-wide profit warnings from August. That will include “optimization” of its generic drug portfolio, including price rises and product terminations in ... Read more →

20170721-pharma-bubbles

Teva Tumbles as Price Deflation Catches Up With Imports

Generic drug manufacturer Teva cut its full year revenue guidance by 5%, in part because of drug price deflation. Its stock price dropped 23% in response. Falling drug prices have been evident in U.S. import data for some time. Panjiva data shows average prices per kg fell 25% in the three mon... Read more →